SEC Form 4 · accession 0001251769-17-000079
Apollo Endosurgery, Inc. · APEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bret Schwartzhoff
Officer — VP, US Sales & Marketing
Period of report
Dec 7, 2017
Accepted (ET)
Dec 11, 2017 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001251769
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 7, 2017 | A | 13,327 | $0.00 | A | 28,958 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1,F3 | $4.37 | Dec 7, 2017 | A | 39,981 | A | — | Dec 7, 2027 | Common Sock | 39,981 | 78,481 | D |
Explanation of responses
- F1Award is issued pursuant to the 2017 Equity Incentive Plan.
- F225% of the total number of shares of common stock subject to the award shall vest on December 7, 2018 and 25% of the total number of shares of common stock subject to the award shall vest annually thereafter, subject to the Reporting Person's continuous service as of each such date.
- F325% of the total number of shares of common stock subject to the option shall vest on December 7, 2018 and 1/48 of the total number of shares subject to the option shall vest monthly thereafter, subject to Reporting Person's continuous service as of each such date.